Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report) shares rose 6.5% during trading on Wednesday . The stock traded as high as $101.60 and last traded at $101.37. Approximately 630,510 shares traded hands during mid-day trading, a decline of 55% from the average daily volume of 1,387,047 shares. The stock had previously closed at $95.15.
Direxion Daily S&P Biotech Bull 3x Shares Stock Up 6.7 %
The company has a fifty day moving average price of $99.69 and a 200 day moving average price of $118.22.
Institutional Trading of Direxion Daily S&P Biotech Bull 3x Shares
A number of institutional investors and hedge funds have recently modified their holdings of the business. Spire Wealth Management bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 4th quarter valued at about $68,000. SG Americas Securities LLC grew its position in shares of Direxion Daily S&P Biotech Bull 3x Shares by 6.0% during the 4th quarter. SG Americas Securities LLC now owns 3,392 shares of the company’s stock worth $305,000 after buying an additional 193 shares in the last quarter. JPMorgan Chase & Co. boosted its position in Direxion Daily S&P Biotech Bull 3x Shares by 129.3% during the third quarter. JPMorgan Chase & Co. now owns 4,851 shares of the company’s stock valued at $625,000 after purchasing an additional 2,735 shares in the last quarter. B. Riley Wealth Advisors Inc. purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at about $279,000. Finally, Tidal Investments LLC purchased a new stake in Direxion Daily S&P Biotech Bull 3x Shares in the third quarter valued at about $9,012,000.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Featured Stories
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- What Investors Need to Know to Beat the Market
- 3 Must-Have ETFs Set to Dominate This Quarter
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- How to Choose Top Rated Stocks
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.